- Home
- IMUX vs AREC Comparison
IMUX vs AREC Comparison
Compare IMUX & AREC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMUX
- AREC
- Stock Information
- Founded
- IMUX 2016
- AREC 2013
- Country
- IMUX United States
- AREC United States
- Employees
- IMUX N/A
- AREC N/A
- Industry
- IMUX Biotechnology: Pharmaceutical Preparations
- AREC Coal Mining
- Sector
- IMUX Health Care
- AREC Energy
- Exchange
- IMUX Nasdaq
- AREC Nasdaq
- Market Cap
- IMUX 67.1M
- AREC 71.7M
- IPO Year
- IMUX N/A
- AREC 2019
- Fundamental
- Price
- IMUX $0.72
- AREC $0.92
- Analyst Decision
- IMUX Strong Buy
- AREC Strong Buy
- Analyst Count
- IMUX 6
- AREC 2
- Target Price
- IMUX $11.60
- AREC $4.00
- AVG Volume (30 Days)
- IMUX 2.4M
- AREC 2.4M
- Earning Date
- IMUX 08-07-2025
- AREC 08-18-2025
- Dividend Yield
- IMUX N/A
- AREC N/A
- EPS Growth
- IMUX N/A
- AREC N/A
- EPS
- IMUX N/A
- AREC N/A
- Revenue
- IMUX N/A
- AREC $321,142.00
- Revenue This Year
- IMUX N/A
- AREC $25,437.66
- Revenue Next Year
- IMUX N/A
- AREC $156.28
- P/E Ratio
- IMUX N/A
- AREC N/A
- Revenue Growth
- IMUX N/A
- AREC N/A
- 52 Week Low
- IMUX $0.56
- AREC $0.38
- 52 Week High
- IMUX $2.11
- AREC $1.68
- Technical
- Relative Strength Index (RSI)
- IMUX 36.47
- AREC 57.10
- Support Level
- IMUX $0.71
- AREC $0.63
- Resistance Level
- IMUX $0.91
- AREC $1.08
- Average True Range (ATR)
- IMUX 0.07
- AREC 0.13
- MACD
- IMUX 0.00
- AREC 0.03
- Stochastic Oscillator
- IMUX 29.20
- AREC 64.47
About IMUX Immunic Inc.
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.
About AREC American Resources Corporation
American Resources Corp constructs and/or purchases and manages a chain of combined gasoline, diesel and natural gas (NG) fueling and service stations; construct conversion factories to convert NG to liquefied natural gas (LNG) and compressed natural gas (CNG); and construct conversion factories to retrofit vehicles currently using gasoline or diesel fuel to also run on NG in the United States and also to build a convenience store to serve its customers in each of its locations. Its segments are AIC focused on the extraction, processing, transportation, and distribution of coal for a variety of industries, with a focus on metallurgical quality coal to the steel industry; RLMT; and EMC.